| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |